Stocktoria
Ocugen, Inc. OCGN
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2014-12-03
Ocugen, Inc. statistics & valuation
Market cap$507.8M
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -1425.7% | -1350.4% | -1085.7% | -3580.0% | — |
| Net margin | -1537.4% | -1333.0% | -1045.0% | -3488.9% | — |
| FCF margin | -1295.0% | -1122.7% | -1201.6% | -2593.9% | — |
| Return on assets | -155.9% | -65.6% | -97.7% | -79.9% | -55.2% |
| Return on equity | 557.7% | -182.4% | -155.5% | -117.3% | -64.0% |
| Debt / equity | -2.26× | 0.92× | 0.07× | 0.03× | 0.02× |
| Current ratio | 1.06 | 2.86 | 2.51 | 3.45 | 14.66 |
| Revenue growth | 8.8% | -32.8% | 142.6% | — | -100.0% |
Source: SEC EDGAR filings · CIK 0001372299 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.